Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Decrease in Short Interest

Aethlon Medical, Inc. (NASDAQ:AEMD) was the target of a significant decrease in short interest in October. As of October 15th, there was short interest totalling 299,300 shares, a decrease of 45.1% from the September 30th total of 544,800 shares. Based on an average daily trading volume, of 1,700,000 shares, the days-to-cover ratio is currently 0.2 days.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on Aethlon Medical in a research report on Wednesday. They set a “sell” rating on the stock.

Aethlon Medical Stock Performance

Shares of Aethlon Medical stock opened at $0.38 on Friday. Aethlon Medical has a fifty-two week low of $0.24 and a fifty-two week high of $2.35. The company has a market capitalization of $5.21 million, a P/E ratio of -0.08 and a beta of 1.74. The company has a fifty day moving average of $0.41 and a 200 day moving average of $0.60.

Aethlon Medical (NASDAQ:AEMD) last released its quarterly earnings data on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.10. During the same period in the prior year, the business posted ($1.30) earnings per share. Analysts forecast that Aethlon Medical will post -1.1 EPS for the current year.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.